

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : TAS-118,Oxaliplatin
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : YAKULT HONSHA CO LTD
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : TAS-118 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Stomach Neoplasms.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 23, 2014
Lead Product(s) : TAS-118,Oxaliplatin
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : YAKULT HONSHA CO LTD
Deal Size : Inapplicable
Deal Type : Inapplicable
